Certified GSP and GDTP
FarmaVita S.A.C.
Leading distributor in the Peruvian pharmaceutical
sector, ensuring quality and safety in our processes.
We are part of the Advance Scientific Group business group and focus on the importation, commercialization, and distribution of high-quality pharmaceuticals and medical devices, always committed to the welfare of Peruvian society and the requirements of the pharmaceutical sector.
FarmaVita Portfolio
Hematology
Medicamentos innovadores de alta calidad, diseñados para mejorar la calidad de vida en pacientes con cáncer y enfermedades hematológicas.
Pediatric Conditions
Fórmulas seguras y eficaces para el manejo clínico en unidades de cuidados intensivos pediátricos y neonatales.
Cardiovascular
Medicamentos que previenen riesgos cardiovasculares, reducen infartos y protegen el sistema circulatorio en pacientes críticos.
Public Health
Productos antibióticos de uso institucional para combatir tuberculosis y patologías infecciosas de alto impacto social.
Certifications
FarmaVita Group is certified in Good Storage Practices (GSP), which enables us to guarantee the conditions of our pharmaceutical products, medical devices, and health products from receipt and storage through the end of the product supply chain.
We hold certification in Good Distribution and Transportation Practices (GDTP), which attests to compliance with high conservation standards for the supply, handling, storage, and transport of human-use medicines and their active pharmaceutical ingredients (APIs).
Innovating to save lives
Commitment
We are a company that understands industry needs and works to ensure the supply of medicines and/or devices required by public and private institutions, complying with GSP and GDTP regulations in Peru.
Experience
We have established commercial alliances with recognized international laboratories, enabling us to supply quality products to various public and private health sector entities.
Innovation
Our challenge is to increase health quality in Latin America by providing innovative technologies to address high-complexity pathologies rapidly and consistently.